Werkgroep Cardiologische centra Nederland

CORYFEE (Completed)

Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr (CORYFEE)
Medicine
Celivarone
Population
Arrhythmia
Phase
II
Starting year
2005
More information
ClinicalTrials.gov